Monday, August 4, 2014

Valeant’s Deal With Ackman May Be Too Clever to Be Legal by ANDREW ROSS SORKIN



By ANDREW ROSS SORKIN


A lawsuit by Allergan says the unusual arrangement by Valeant Pharmaceuticals and William A. Ackman amounts to insider trading, and the judge’s decision will rest upon a set of arcane financial rules.


Published: August 4, 2014 at 4:00AM


from NYT Business Day http://ift.tt/1omXMD9






from WordPress http://ift.tt/1ugW8Zq

via Hadi Aboukhater
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)